AVTX
Avalo Therapeutics, Inc.
$18.55
+0.13 (+0.71%)
At close · Jul 15
Market Cap
$975.09M
Shares
52,565,572
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-06-01 | $75,000,000 | — | — | — | 10-Q , filed 2026-05-13 |